Recent advances in peptide-based therapy for Type 2 diabetes and obesity

JM Conlon, PR Flatt, CJ Bailey

Research output: Contribution to specialist publicationEditorial

Abstract

The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.
Original languageEnglish
Volume145
No.170652
Specialist publicationPeptides
DOIs
Publication statusPublished - 20 Sep 2021

Fingerprint

Dive into the research topics of 'Recent advances in peptide-based therapy for Type 2 diabetes and obesity'. Together they form a unique fingerprint.

Cite this